Plaintiffs allege cancer drug Taxotere causes permanent hair loss, sue manufacturer
The first case in multi-district litigation (MDL) revolving around permanent hair loss from a breast cancer drug has been set for trial in September 2018.
Sanofi US
Recent News About Sanofi US View More
Aventis Pharma et al allegedly failed to warn cancer patients of Taxotere's side effects
NEW ORLEANS — A breast cancer patient has filed suit against three drug manufacturing companies for alleged design defect, failure to warn and breach of express warranty.
Alerts Sign-up